Patent Application
20220128557
The present invention is in the field of cell monitoring.
The Center for Disease Control (CDC) estimates that in the United States, more than two million people are sickened every year with antibiotic-resistant infections, with at least 23,000 dying as a result. Further it emphasizes the importance of developing improved diagnostic tools—which are needed to determine resistance profiles to inform the appropriate use of drugs. Such tools should also reduce the widespread overuse and misuse of the current antibiotic arsenal.
The most important outcome of any antimicrobial susceptibility testing (AST) is the rapid and reliable prediction of a successful antimicrobial agent in the treatment of infection. Limited numbers of methods for AST of medically important microorganisms have survived the maturation of modern diagnostic clinical microbiology.
In vitro AST can be performed using a variety of phenotypic formats, the most common being disk diffusion, agar dilution, broth microdilution and a concentration gradient test. At present, expensive nucleic acid-based AST methods cannot detect all resistance markers, and thus have not been widely adopted. Next generation whole genome sequencing is confounded by the ever-elevating degree of genetic heterogeneity, a persistent problem expected to frustrate the genomic approach. There are hundreds of β-lactamases and numerous mutations, acquisitions and expression mechanisms that result in fluoroquinolone, aminoglycoside and macrolide resistance; too many to be easily detected by current molecular techniques. Thus, it is likely that phenotypic measures of the level of susceptibility of bacterial isolates to antimicrobial agents will continue to be clinically relevant for years to come.
Currently, AST is typically accomplished using either classical manual methods or growth-dependent automated systems. The major limitations of these methods include the requirement for relatively large numbers of viable starting organisms, complicated pre-analytical processing, limited organism spectrum, analytical variability, lengthy time to results and cost. The standard diagnostic techniques have not significantly changed during the past 20 years, though these techniques have been adapted into automated instruments and optimized. Still, the complete analysis time has typically improved by only 10-12 hours, which still translates into two working days to provide AST analysis, at best. The laboratory automatization is limited (due to cost and infrastructure) to consolidated central labs, such as large hospital and regional service labs. Local clinics, small hospitals, senior residence, day care facilities and other medical institutions either perform the classic labor-intensive AST or transport patient's samples to centralized locations for automated processing. This intensifies the problem of AST cost and duration, adding the cost and time consumed by transportation. Thus, in the absence of rapid definitive microbiological diagnosis at the point of care (POC), physicians frequently initiate empirical broad-spectrum antibiotic treatment. This leads in many cases to significantly increased risk of clinical adverse outcome, increased mortality, and has contributed to the emergence of resistant pathogens. There is an urgent, recognizable, need for development of new automated instruments that can provide faster results and also save money by virtue of lower reagent costs and reduced labor requirements.
The present invention provides systems for measuring cellular growth comprising a diffraction grating, a light source configured to illuminate at a limited waveband, an optical detection system configured to detect zero and non-zero diffraction orders of light, and a signal processing unit adapted to analyze zero and non-zero diffraction orders to determine time-dependent changes in effective optical depth, as well as methods of use thereof.
According to a first aspect, there is provided a system, the system comprising:
According to another aspect, there is provided a method for real-time detection of cell replication or growth, the method comprising:
thereby detecting cell replication or growth in real-time.
According to another aspect, there is provided a method of selecting a therapeutic agent for treating growth of a cell, the method comprising:
thereby selecting a therapeutic agent for treating growth of the cell.
According to another aspect, there is provided a method of determining the presence of a cell in a sample, the method comprising:
thereby determining the presence of the cell in the sample.
According to another aspect, there is provided a computer program product, comprising a non-transitory computer-readable storage medium having program code embodied thereon, the program code, when executed by a data processor, causes the data processor to calculate differences in zero and non-zero diffraction orders of monochromatic light detected over time to determine changes in effective optical depth of diffraction gratings that produced the zero and non-zero diffraction orders of monochromatic light.
According to some embodiments, the cell is a microorganism, and optionally a bacterium.
According to some embodiments, the system is for use in measuring growth of a cell.
According to some embodiments, the diffraction grating is coated with a cell attractant, and optionally wherein the cell attractant is a sugar. According to some embodiments, the diffraction grating contains a liquid suitable for cell survival and optionally wherein the cell attractant is configured to diffuse into the liquid thereby creating a concentration gradient. According to some embodiments, the cell attractant is attached to the grating by hydrogen bonds to double-bond oxygen on the grating and optionally wherein the grating comprises an active group that comprises the double-bond oxygen.
According to some embodiments, the light source is a laser, laser diode or a light emitting diode (LED). According to some embodiments, the light source is a laser and configured to illuminate at a waveband of at most 5 nm.
According to some embodiments, the optical detection system comprises a light intensity detector. According to some embodiments, the optical detection system is configured to detect at least a first and second order diffraction of the light beam.
According to some embodiments, the system further comprises a housing and a fluid inlet and outlet and wherein at least the diffraction grating is deposed in the housing.
According to some embodiments, the system is deposed within a water dispenser.
According to some embodiments, the method is for use in determining the identity of the cell in a sample, wherein the sample is administered into a plurality of diffraction gratings comprising at least two different selective growth media in different diffraction gratings and wherein growth in a particular selective growth media indicates the identity of the cell.
According to some embodiments, the cell is from an infectious microorganism. According to some embodiments, the cell is a cancer cell.
According to some embodiments, the cell is extracted from a subject that has or is suspected of having a microorganism infection or cancer. According to some embodiments, the sample is a sample taken from a subject in need thereof.
According to some embodiments, the sample is a water sample.
According to some embodiments, the processing of diffraction orders comprises processing at least two, non-zero, diffraction orders and wherein an increase in the difference between intensities of an odd order and an even order indicates an increase in effective optical depth and an increase in the amount of cellular material in the grating.
According to some embodiments, the cellular material comprises any one of:
According to some embodiments, the determining changes in effective optical depth comprises calibration of the detector by detecting diffraction orders' intensity obtained from illumination of the diffraction grating absent the at least one cell or sample.
According to some embodiments, the method further comprises adding a test agent to the grating after inoculation, wherein the test agent has the potential to alter at least one of the viability, replication, motility, metabolism, protein production, lipid production and secretion of the at least one cell and optionally wherein the at least one therapeutic or test agent is selected from the group consisting of an antibiotic, a chemotherapeutic, a radioisotope, a fungicide, a biostatic agent, an antibody, an immune cell and a virus.
According to some embodiments, the inoculating comprises a final concentration of cells within the diffraction grating of at least 3 cells per square millimeter of the diffraction grating.
According to some embodiments, the method is performed in not more than 90 minutes.
According to some embodiments, the data processor calculates time-dependence of the differences in zero and non-zero diffraction orders and optionally determines a change in an amount of a biomaterial within the diffraction gratings. According to some embodiments, the calculating comprises comparing odd and even orders of diffraction.
Further embodiments and the full scope of applicability of the present invention will become apparent from the detailed description given hereinafter. However, it should be understood that the detailed description and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
The present invention, in some embodiments, provides systems for measuring cellular growth, comprising a diffraction grating, a light source configured to illuminate at a limited waveband, an optical detection system configured to detect zero and non-zero diffraction orders of light, and a signal processing unit adapted to analyze zero and non-zero diffraction orders to determine time-dependent changes in effective optical depth. The present invention further concerns methods for use of these systems for real-time detection of cell growth or deterioration, detection of a cell in a sample, such as a water sample, determining the identity of a bacterial cell and for determining the sensitivity of infectious microorganisms to therapeutic agents, such as may be used in the treatment of an infection in a subject in need thereof.
By a first aspect, there is provided a system, the system comprising:
In some embodiments, the system is for measuring growth of a cell. In some embodiments, the system is for measuring changes in an amount of biomaterial or cellular material. In some embodiments, the system is for use in real-time detection. In some embodiments, the system is for use in real-time detection of cell replication. In some embodiments, the system is for use in real-time measuring of cell growth. In some embodiments, the system is for use in real-time detection of changes in an amount of biomaterial or cellular material.
In some embodiments, the signal processing unit is configured to convert the time-dependent changes in effective optical depth into measures of cellular growth, biomaterial, cellular material and/or cellular replication. Each possibility represents a separate embodiment of the invention. In some embodiments, the signal processing unit determines from the changes in effective optical depth the growth of a cell in the grating. In some embodiments, the changes in optical depth are referred to as a shift. In some embodiments, the shift is a relative change in diffraction intensity. In some embodiments, a decrease in effective optical depth indicates an increase in cell growth, biomaterial or cellular replication. In some embodiments, a large positive shift indicates an increase in cell growth, biomaterial or cellular replication. In some embodiments, the shift is at least 0.02, 0.021, 0.022, 0.023, 0.024, 0.025, 0.026, 0.027, 0.028, 0.029, 0.03, 0.031, 0.032, 0.033, 0.034, or 0.035% increase in diffraction intensity. Each possibility represents a separate embodiment of the invention.
By another aspect, there is provided a method for real-time detection of cell growth or replication, the method comprising:
thereby detecting cell growth or replication in real-time.
In some embodiments, the method is for measuring changes in an amount of biomaterial or cellular material. In some embodiments, the method is for real-time detection. In some embodiments, the method is for real-time detection of changes in an amount of biomaterial or cellular material. In some embodiments, the cell is a cell of a microorganism.
By another aspect, there is provided a method of selecting a therapeutic agent for treating growth of a cell, the method comprising:
By another aspect, there is provided a method of determining the presence of a cell in a sample, the method comprising:
By another aspect, there is provided a method of determining the identity of a cell in a sample, the method comprising:
In some embodiments, the cell is a prokaryotic or a eukaryotic cell. In some embodiments, the cell is a prokaryotic cell. In some embodiments, the cell is a eukaryotic cell. In some embodiments, the cell is a microorganism. In some embodiments, the cell is a cell of a microorganism. In some embodiments, the microorganism is an infectious microorganism. In some embodiments, the cell is a bacterial cell. In some embodiments, the cell is a fungal cell. In some embodiments, the microorganism is a bacterium or a fungus. In some embodiments, the microorganism is a bacterium. In some embodiments, the microorganism is a fungus. In some embodiments, the microorganism is a parasite. In some embodiments, the microorganism is selected from a bacterium, a fungus and a parasite. In some embodiments, the microorganism is from a subject in need of treatment for infection by the microorganism. In some embodiments, the cell is a mammalian cell. In some embodiments, the cell is a human cell. In some embodiments, the cell is a cancer cell. In some embodiments, the cell is a virus infected cell. In some embodiments, the cell is extracted from a subject in need thereof. In some embodiments, a subject in need thereof is a subject that has cancer. In some embodiments, a subject in need thereof is a subject suspected of having cancer. In some embodiments, a subject in need thereof is a subject that has a microorganism infection. In some embodiments, a subject in need thereof is a subject suspected of having a microorganism infection. In some embodiments, a subject in need thereof is a subject that has cancer or a microorganism infection. In some embodiments, a subject in need thereof is a subject suspected of having cancer or a microorganism infection.
In some embodiments, treating growth of a cell is treating a microorganism infection. In some embodiments, treating is killing. In some embodiments, treating is slowing, retarding or arresting growth. Each possibility represents a separate embodiment of the invention. In some embodiments, treating is a treatment that would treat a subject comprising the cell. In some embodiments, the cell is a cell of a microorganism and treating growth of the cell comprises treating a subject infected with the microorganism. In some embodiments, the cell is a cancer cell and treating growth of the cell comprises treating a subject with the cancer.
In some embodiments, the sample is a water sample. In some embodiments, the water sample is suspected of having a microorganism growing within it. In some embodiments, the water sample is a drinking water sample. In some embodiments, the water sample is an irrigation sample. In some embodiments, the drinking water sample is from a water pipe. In some embodiments, the water sample is from a water cooler, or domestic water appliance. As used herein, the term “domestic water appliance” refers to any home appliance that uses water. Examples of domestic water appliances include, but are not limited to water coolers, water bubblers, refrigerators, freezers, ice makers, drink carbonators, coffer/espresso machines, and vacuums.
In some embodiments, the system is for measuring changes in the amount of biomaterial present in a compartment. As used herein, “biomaterial” refers to any biological material produced by an organism. In some embodiments, biomaterial comprises secretions, extracellular matrix, proteins, lipids, organelles, membranes, cells, portions thereof, and combinations thereof. In some embodiments, cellular material comprises secretions, extracellular matrix, proteins, lipids, organelles, membranes, cells, portions thereof, and combinations thereof. In some embodiments, biomaterial comprises viruses. In some embodiments, the biomaterial is a replicating virus and thus comprises virus infected cells.
In some embodiments, the method is for use in determining the identity of a cell in a sample. In some embodiments, the sample is administered into a plurality of diffraction gratings. In some embodiments, the plurality of diffraction gratings comprises at least two different selective growth media. In some embodiments, the at least two different selective growth media are in different diffraction gratings. It will be understood that the two media are not mixed in the same diffraction media. As used herein, the term “selective growth media” refers to media with a composition that only certain cells will grow on them. This can be due to the media have composition that promotes cell growth, enables cell growth, delays cell growth or arrests cell growth of certain cells. Selective media are well known in the art and may contain specific carbon sources or specific amino acids or other drugs or molecules that enable growth or inhibit growth by certain cells. In some embodiments, the selective media is selective for certain bacteria. In some embodiments, selective media is differential media. By using a sufficient number of different media with different characteristics the exact identity or a general identity of the cell that is in the sample can be determined. Examples of selective media include but are not limited to, eosin methylene blue containing media, YM media with low pH, Thayer-Martin medium, xylose lysine desoxyscholate containing media, MacConkey media, and X-gal containing media.
As used herein, the term “identifying” a cell refers to determining information about the cell. In some embodiments, identifying is determining the domain of the cell. In some embodiments, identifying is determining the kingdom of the cell. In some embodiments, identifying is determining the phylum of the cell. In some embodiments, identifying is determining the class of the cell. In some embodiments, identifying is determining the order of the cell. In some embodiments, identifying is determining the family of the cell. In some embodiments, identifying is determining the genus of the cell. In some embodiments, identifying is determining the species of the cell. In some embodiments, identifying is determining the cell type of the cell. In some embodiments identifying is determining the microorganism of origin of the cell. In some embodiments identifying is determining the antibody resistance of the cell.
It will be understood by one skilled in the art that the systems of the invention can be used to measure optical response. Optical response comprises, among other elements, changes in the optical depth of the compartments of the grating. When any biological organism capable of reproducing is put in the grating the system can measure its rate of reproduction. The system does this in real-time as there can be continuous monitoring of the compartments. Further, by employing light with a limited waveband and analyzing zero and non-zero diffraction orders, very small changes in the effective optical depth can be detected. Thus, the system of the invention can detect even secretions, alterations of the extracellular matrix, creation of or alterations in a biofilm or enhanced intracellular volume that occur before a cycle of replication and can thus detect normal replication faster than any method currently existing in the art.
As used herein, a “diffraction grating” refers to a two-dimensional (2D) or 1 D array of compartments, where the compartments have a dimension larger than the wavelength of light that is produced by the light source. In some embodiments, the array of compartments is ordered. In some embodiments all the compartments are identical in dimension. In some embodiments, the array comprises an irregular distribution. It will be understood that the compartment shape can vary or be constant and that the compartment dimensions can vary or be constant so long as the compartments comprise a dimension larger than the wavelength of the light that is produced by the light source. Examples of shapes of the compartments include, but are not limited to, squares, rectangles, circles, ovals and semi-circles. The compartments may be flat or rounded on the bottom or bottomless. Further, the compartments can be perforated or solid. In some embodiments, the compartment is transparent. In some embodiments, the compartment has a dimension such that a cell can fit therein. In some embodiments, the dimension is a lateral dimension. In some embodiments, the compartment is configured to be of a size sufficient for a cell to fit therein.
In some embodiments, the diffraction grating comprises a lamellar phase grating. In some embodiments, the diffraction grating comprises a photonic lamellar grating. In some embodiments, the diffraction grating comprises an ordered grating grid. In some embodiments, the diffraction grating is composed from transparent material. In some embodiments, the diffraction grating is composed from reflective material. In some embodiments, the diffraction grating is silicon based. In some embodiments, the diffraction grating is made from an inorganic material. In some embodiments, the diffraction grating is made from an organic material. In some embodiments, the diffraction grating is made from an organic or inorganic material. In some embodiments, a first portion of the diffraction grating will have a higher refraction index than a second portion of the diffraction grating. In some embodiments, the diffraction grating is etched in a silicon wafer. In some embodiments, the grating comprises at least one compartment configured to hold cells. In some embodiments, the grating comprises an array of compartments. In some embodiments, the grating is one-dimensional. In some embodiments, the grating is two-dimensional. In some embodiments, the grating is a linear grating. In some embodiments, the linear grating comprises at least 10, 50, 100, 200, 300, 400, 500, 600, 700, 800, 900 or 1000 compartments per mm, aligned linearly. Each possibility represents a separate embodiment of the invention. In some embodiments, the grating comprises up to 10000, 20000, 30000, 40000, 50000, 60000, 70000, 80000, 90000, 1000000, 200000, 300000, 400000, or 500000 compartments per square millimeters (mm2). In some embodiments, the grating comprises up to 100,000 compartments per mm2.
The terms “compartments” and “wells” are used herein interchangeably and refer to an enclosed part of the diffraction grating of sufficient size to hold the biological material that is being analyzed. It will be understood that the well must have sufficient space to allow cellular replication to proceed unimpeded by the dimensions of the well. In some embodiments, the well is configured to have sufficient room for the volume of media needed to provide non-limiting amounts of nutrients to the biological material. In some embodiments, the well is open to a reservoir of media. In some embodiments, the compartment has lateral dimensions such that at least 1, 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 cells can fit therein. Each possibility represents a separate embodiment of the invention. In some embodiments, the compartment has lateral dimensions such that at most 75, 100, 125, 150, 175, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 5000, 10000, or 50000 cells can fit therein. Each possibility represents a separate embodiment of the invention. In some embodiments, the cells must adhere to the surface of the wells. In such embodiments, there must be sufficient room for the cells to adhere and reproduce without the space becoming limiting in the time frame of the detection. In some embodiments, well is configured to hold cells from at least one replication cycle. In some embodiments, the well is configured to hold cells from up to 2, 3, 4, 5, 6, 7, 8, 9, or 10 replication cycles. Each possibility represents a separate embodiment of the invention. In some embodiments, the well is configured to hold cells from up to 10 replication cycles. In some embodiments, the compartment has lateral dimensions such that at least 1, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 or 1000 cells can adhere therein. Each possibility represents a separate embodiment of the invention. In some embodiments, the well is configured to hold at least 1, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 or 1000 cells within half its volume. Each possibility represents a separate embodiment of the invention. In some embodiments, the well is configured to hold about 100 cells in half its volume.
It will be understood by one skilled in the art that the system and methods of the invention are for use with a diffraction grating that has a dimension greater than the wavelength of light being used. Though biomaterial may be smaller than the wavelength of light being used, for example, a virus, though much smaller than the wavelength of light still requires a host cell with dimensions larger than the wavelength of light.
In some embodiments, the diffraction grating comprises cell growth media. In some embodiments, the cell growth media is provided to the diffraction grating. In some embodiments, the cell is added to the cell growth media in the diffraction grating. Cell growth media is well known in the art, and various medias exist for different cell types. Examples of cell growth media include, but are not limited to DMEM, RPMI, Muller-Hinton Broth, and LB medium. In some embodiments, the cell growth media is a liquid. In some embodiments, the cell growth media is not a solid.
In some embodiments, the surface of the grating and/or compartment is configured to promote cell adhesion. In some embodiments, the diffraction grating, and/or a compartment therein comprises isopropenyl-ester or propylmethcrylate surface functional groups. In some embodiments, the diffraction grating, and/or a compartment therein comprises isopropenyl-ester functional groups. In some embodiments, the diffraction grating, and/or a compartment therein comprises propylmethcrylate surface functional groups. In some embodiments, the diffraction grating, and/or a compartment therein comprises surface double bond oxygen functional groups. In some embodiments, the diffraction grating, and/or a compartment therein comprises surface alkyl functional groups. In some embodiments, the surface groups increase cell adhesion to the surface. In some embodiments, the surface groups increase cell adhesion to the surface relative to a surface that does not have the functional groups. In some embodiments, the surface groups increase cell adhesion by at least 1%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90, 100%, 200%, 300%, 400%, 500%, 600%, 700%, 800%, 900%, 1000%, 2000%, 3000%, 4000%, 5000%, 7500%, or 10000%. Each possibility represents a separate embodiment of the invention. In some embodiments, the surface groups increase cell adhesion by at least 1000%. In some embodiments, the surface groups reduce settlement and colonization time by at least 1%, 5%, 10%, 20%, 20%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 97%, or 99%. Each possibility represents a separate embodiment of the invention. In some embodiments, the surface groups result in the subsequent cells' exponential growth phase faster than if there were no attractant. In some embodiments, the surface groups reduce the time until exponential growth by at least 1%, 5%, 10%, 20%, 20%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 97%, or 99%. Each possibility represents a separate embodiment of the invention. In some embodiments, the surface groups result in a reduction of the time needed to complete the analysis of the cells' growth. In some embodiments, the reduction in time is a reduction of at least 1%, 5%, 10%, 20%, 20%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 97%, or 99%. Each possibility represents a separate embodiment of the invention.
In some embodiments, the diffraction grating, and/or a compartment herein is coated with a cell attractant. In some embodiments, only the inside of a compartment is coated with a cell attractant. In some embodiments, only the bottom of a well where the cells are to adhere is coated with a cell attractant. As used herein, the term “cell attractant” refers to any molecule that will recruit the cell to the site of the attractant. In some embodiments, the cell attractant recruits the cell by chemotaxis. In some embodiments, the cell attractant is configured to diffuse from the surface of the well into the surrounding media, thereby creating a concentration gradient. In some embodiments, the concentration gradient: recruits the cell by chemotaxis. In some embodiments, the cell attractant is sugar molecules. In some embodiments, the sugar is sucrose. In some embodiments, the cell attractant is adsorbed to a surface of the compartment. In some embodiments, the cell attractant is adhered to a surface of the compartment. In some embodiments, the cell attractant is semi-stably adsorbed to a surface of the compartment. In some embodiments, the cell attractant is semi-stably adhered to a surface of the compartment. In some embodiments the surface is the bottom of the compartment where the cells are to adhere. In some embodiments, the semi-stable attractant is stable enough to remain on the surface when the compartment is dry, but upon addition of a liquid, such as media, the attractant can diffuse into the media thereby creating a gradient. In some embodiments, the grating with the attractant is kept wet at all times.
In some embodiments, the cell attractant facilitates faster settlement and colonization of cells to the surface of the well than if there were no attractant. In some embodiments, the cell attractant improved inoculation efficiency. In some embodiments, the attractant increases inoculation efficiency by at least 1%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90, 100%, 200%, 300%, 400%, 500%, 600%, 700%, 800%, 900%, 1000%, 2000%, 3000%, 4000%, 5000%, 7500%, or 10000%. Each possibility represents a separate embodiment of the invention. In some embodiments, the attractant reduces settlement and colonization time by at least 1%, 5%, 10%, 20%, 20%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 97%, or 99%. Each possibility represents a separate embodiment of the invention. In some embodiments, the attractant reduces settlement and colonization time by at least 90%. In some embodiments, the cell attractant results in the subsequent cells' exponential growth phase faster than if there were no attractant. In some embodiments, the attractant reduces the time until exponential growth by at least 1%, 5%, 10%, 20%, 20%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 97%, or 99%. Each possibility represents a separate embodiment of the invention. In some embodiments, the attractant reduces the time until exponential growth by at least 90%. In some embodiments, the cell attractant results in a reduction of the time needed to complete the analysis of the cells' growth. In some embodiments, the reduction in time is a reduction of at least 1%, 5%, 10%, 20%, 20%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 97%, or 99%. Each possibility represents a separate embodiment of the invention. In some embodiments, the reduction in time is a reduction of at least 90%.
As used herein, the term “limited waveband” refers to light with a limited range of wavelengths. In some embodiments, the light is of a wavelength between 400 and 2000 nm. In some embodiments, limited waveband light is monochromatic light. In some embodiments, the light source is a monochromatic light source. In some embodiments, the light source is configured to illuminate at a limited waveband of not more than 1, 2, 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 nm. Each possibility represents a separate embodiment of the invention. In some embodiments, the light source is configured to illuminate at a limited waveband of not more than 50 nm. In some embodiments, the light source is configured to illuminate at a limited waveband of not more than 25 nm. In some embodiments, limited waveband light is light with a bandwidth of not greater than 2, 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 nm. Each possibility represents a separate embodiment of the invention. In some embodiments, limited waveband light is light with a bandwidth of not greater than 50 nm. In some embodiments, limited waveband light is light with a bandwidth of not greater than 20 nm. In some embodiments the light is about a specific wavelength. In some embodiments, the light is laser light. In some embodiments, the light source is a laser. In some embodiments, the light source is a laser and the light has a limited waveband of not more than 5 nm. In some embodiments, the light source is a laser, laser diode (LD) or a light emitting diode (LED). In some embodiments, the light source is a LD. In some embodiments, the light source is a LED. In some embodiments, the light source is a LED and the light has a limited waveband of not more than 25 nm.
In some embodiments, monochromatic light is light of only one color based on the wavelength of the light. In some embodiments, red light is light between the wavelengths of 740 and 625 nanometers (nm). In some embodiments, red light is light between the wavelengths of 740 and 620 nm. In some embodiments, orange light is light between the wavelengths of 625 and 590, 625 and 585, 620 and 590 or 620 and 595 nm. Each possibility represents a separate embodiment of the invention. In some embodiments, yellow light is light between the wavelengths of 590 and 565, 590 and 560, 585 and 565 or 585 and 560 nm. Each possibility represents a separate embodiment of the invention. In some embodiments, green light is light between the wavelengths of 565 and 520, 565 and 500, 560 and 520 or 560 and 500 nm. Each possibility represents a separate embodiment of the invention. In some embodiments, cyan light is light between the wavelengths of 520 and 500, 520 and 480, or 500 and 480 nm. Each possibility represents a separate embodiment of the invention. In some embodiments, blue light is light between the wavelengths of 500 and 450, 500 and 435, 490 and 450, 490 and 435, 480 and 450 or 480 and 435. Each possibility represents a separate embodiment of the invention. In some embodiments, violet light is light between the wavelengths of 450 and 400, 450 and 380, 435 and 400 or 435 and 380 nm. Each possibility represents a separate embodiment of the invention.
In some embodiments, the laser light is red light. In some embodiments, the laser emits light with a wavelength of about 650 nm. In some embodiments, the light is not white light. In some embodiments, the light is not broadband light. In some embodiments, the light source does not emit a range of wavelengths. In some embodiments, the light source does not emit a spectrum of light.
As used herein, the term “coherent light” refers to light where the phase difference between the waves is constant such that the waves do not interfere with each other over a given distance. Coherent light sources are well known in the art and include lasers and LEDs. In some embodiments, the light source produces coherent light. In some embodiments, the light that hits the diffraction grating is coherent light. In some embodiments, the light has a coherence length of at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, or 25 cm. Each possibility represents a separate embodiment of the invention. In some embodiments, the light has a coherence length of at least 1 cm.
In some embodiments, the light source is not perpendicular to the grating. In some embodiments, the light source is not normal to the grating. In some embodiments, the light hits the grating at any angle between 45 and 90 degrees. In some embodiments, the light hits the grating at any angle between 45 and 89 degrees. Each possibility represents a separate embodiment of the invention. In some embodiments, the light does not hit the grating at 90 degrees. In some embodiments, the light beam is coherent. In some embodiments, the light beam is collimated. In some embodiments, the light beam is coherent or collimated. In some embodiments, the light beam is coherent and collimated. In some embodiments, the system of the invention comprises a filter for colimiting the light.
As used herein, the terms “optical detection system” and “detector” are used synonymously and refer to an apparatus that is configured to detect the light emitted from the light source. In some embodiments, the optical detection system is configured to detect the diffraction intensities from narrow-band light. In some embodiments, the optical detection system is configured to detect the diffraction intensities from monochromatic light. In some embodiments, the optical detection system is not configured to detect white light, broadband light, or polychromatic light. Each possibility represents a separate embodiment of the invention. In some embodiments, the detector is an active pixel sensor (APS). In some embodiments, the APS is a complementary metal-oxide semiconductor (CMOS) sensor. In some embodiments, the detector is a charge-coupled device (CCD) sensor. In some embodiments, the detector comprises a light to frequency converter. In some embodiments, the light to frequency converter is a TSL253R light to frequency converter. In some embodiments, the sensor is a Pi Camera. In some embodiments, the sensor is a Raspberry Pi Camera.
In some embodiments, the optical detection system is configured to detect zero-order diffraction. In some embodiments, the optical detection system is configured to detect zero and no-zero diffraction orders. In some embodiments, the optical detection system is configured to detect non-zero diffraction orders. In some embodiments, the optical detection system is configured to detect all non-zero diffraction orders. In some embodiments, the system is configured to detect at least first and second order diffraction. In some embodiments, the system is configured to detect at least zero, first and second order diffraction. In some embodiments, the system is configured to detect at least two non-zero order diffractions. In some embodiments, the system is configured to detect at least a pair of odd and even order diffractions. In some embodiments, the system is configured to detect at least a pair of adjacent odd and even order diffractions. In some embodiments, measuring two non-zero diffraction orders provide more data than measuring zero order diffraction. In some embodiments, measuring zero and two non-zero diffraction orders provide more data than measuring just zero order diffraction. In some embodiments, measuring two non-zero diffraction orders provide greater resolution than measuring zero order diffraction. In some embodiments, measuring two non-zero diffraction orders allow for real time monitoring of a single compartment.
In some embodiments, the signal processing unit is adapted to analyze non-zero diffraction orders. In some embodiments, the signal processing unit is adapted to analyze zero order diffraction. In some embodiments, the signal processing unit is adapted to analyze zero and non-zero diffraction orders. In some embodiments, the signal processing unit is adapted to determine time-dependent changes in effective optical depth of a grating. In some embodiments, the signal processing unit is adapted to determine time-dependent changes in effective optical depth of the grating. In some embodiments, the signal processing unit is adapted to determine a rate of cell growth. In some embodiments, the signal processing unit is adapted to determine a rate of change of biomaterial.
In some embodiments, the system further comprises a housing. In some embodiments, the system is deposed within the housing. In some embodiments, at least the diffraction grating is deposed in the housing. In some embodiments, the system further comprises a fluid inlet. In some embodiments, the sample and/or cell is brought to the diffraction grating via the fluid inlet. The fluid inlet may be a pipe, tube, trough or any similar structure that can bring a fluid to the diffraction grating. In some embodiments the system further comprises a fluid outlet. In some embodiments, the diffraction grating is deposed between the fluid inlet and outlet. In some embodiments, the diffraction grating is deposed within a housing with a fluid inlet and outlet into and out of the housing respectively. In some embodiments, the other components of the system are also deposed in the housing. In some embodiments, the other components of the system are deposed outside the housing. In some embodiments, the light source is outside the housing. In some embodiments, the light source is within the housing. In some embodiments, the optical detection system is outside the housing. In some embodiments, the optical detection system is inside the housing. In some embodiments, the signal processing unit is inside the housing. In some embodiments, the signal processing unit is outside the housing. In some embodiments, the system of the invention is configured to be deposited within a water using domestic appliance such that it can monitor cell growth within the appliance, or within the water inside the appliance. In some embodiments, the water using domestic appliance is a water dispenser. In some embodiments, the housing is deposed within a water dispenser. In some embodiments, at least the diffraction grating is deposed within a water dispenser. It will be understood that bacterial growth for instance in household appliances can be detrimental. If those appliances contain or have passing through them drinking water bacterial growth can be dangerous. As such the system of the invention can be installed into an appliance to monitor bacterial growth. In some embodiments, the system or at least the diffraction grating is deposited within a water filter. In some embodiments, the system further comprises a signal to notify when cellular growth reaches a predetermined threshold. In some embodiments, the signal processing unit is adapted to produce an output that indicates when the level or bacterial growth and/or that indicates when bacterial growth has reached a threshold level. In this way the system, can give an output such as an alarm or light that tells a user that an appliance should be cleaned or served due to bacterial growth.
By another aspect, there is provided a computer program product, comprising a non-transitory computer-readable storage medium having program code embodied thereon, the program code, when executed by a data processor, causes the data processor to calculate differences in zero and non-zero diffraction orders of narrow-band light detected over time to determine changes in effective optical depth of diffraction gratings that produced said diffraction orders of narrow-band light. In some embodiments, the data processor calculates differences in non-zero diffraction orders of narrow-band light detected over time.
In some embodiments, said differences are differences in intensity. In some embodiments, the data processor calculates time-dependence of the differences in zero order diffraction, non-zero diffraction orders or both. In some embodiments, the data processor further determines a change in an amount of a biomaterial within the diffraction gratings. In some embodiments, the time-dependence is indicative of the growth kinetics of the biomaterial. In some embodiments, the calculating comprises comparing adjacent odd and even orders of diffraction. In some embodiments, the calculating comprises comparing odd and even orders of diffraction. In some embodiments, the calculating comprises comparing at least two non-zero orders of diffraction. In some embodiments, the calculating comprises finding the difference in intensity of adjacent odd and even orders of diffraction. In some embodiments, the calculating comprises finding the difference in intensity of a pair of odd and even orders of diffraction. In some embodiments, the calculating comprises finding the difference in intensity of at least two non-zero orders of diffraction.
The computer readable storage medium can be a tangible device that can retain and store instructions for use by an instruction execution device. The computer readable storage medium may be, for example, but is not limited to, an electronic storage device, a magnetic storage device, an optical storage device, an electromagnetic storage device, a semiconductor storage device, or any suitable combination of the foregoing. A non-exhaustive list of more specific examples of the computer readable storage medium includes the following: a portable computer diskette, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or Flash memory), a static random access memory (SRAM), a portable compact disc read-only memory (CD-ROM), a digital versatile disk (DVD), a memory stick, a floppy disk, a mechanically encoded device such as punch-cards or raised structures in a groove having instructions recorded thereon, and any suitable combination of the foregoing. A computer readable storage medium, as used herein, is not to be construed as being transitory signals per se, such as radio waves or other freely propagating electromagnetic waves, electromagnetic waves propagating through a waveguide or other transmission media (e.g., light pulses passing through a fiber-optic cable), or electrical signals transmitted through a wire.
Computer readable program instructions described herein can be downloaded to respective computing/processing devices from a computer readable storage medium or to an external computer or external storage device via a network, for example, the Internet, a local area network, a wide area network and/or a wireless network. The network may comprise copper transmission cables, optical transmission fibers, wireless transmission, routers, firewalls, switches, gateway computers and/or edge servers. A network adapter card or network interface in each computing/processing device receives computer readable program instructions from the network and forwards the computer readable program instructions for storage in a computer readable storage medium within the respective computing/processing device.
Computer readable program instructions for carrying out operations of the present invention may be assembler instructions, instruction-set-architecture (ISA) instructions, machine instructions, machine dependent instructions, microcode, firmware instructions, state-setting data, or either source code or object code written in any combination of one or more programming languages, including an object oriented programming language such as Java, Smalltalk, C++ or the like, and conventional procedural programming languages, such as the “C” programming language or similar programming languages. The computer readable program instructions may execute entirely on the user's computer, partly on the user's computer, as a stand-alone software package, partly on the user's computer and partly on a remote computer or entirely on the remote computer or server. In the latter scenario, the remote computer may be connected to the user's computer through any type of network, including a local area network (LAN) or a wide area network (WAN), or the connection may be made to an external computer (for example, through the Internet using an Internet Service Provider). In some embodiments, electronic circuitry including, for example, programmable logic circuitry, field-programmable gate arrays (FPGA), application-specific integrated circuits (ASIC) or programmable logic arrays (PLA) may execute the computer readable program instructions by utilizing state information of the computer readable program instructions to personalize the electronic circuitry, in order to perform aspects of the present invention.
These computer readable program instructions may be provided to a processor of a general-purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer or other programmable data processing apparatus, create means for implementing the functions/acts specified in the flowchart and/or block diagram block or blocks. These computer readable program instructions may also be stored in a computer readable storage medium that can direct a computer, a programmable data processing apparatus, and/or other devices to function in a particular manner, such that the computer readable storage medium having instructions stored therein comprises an article of manufacture including instructions which implement aspects of the function/act specified in the flowchart and/or block diagram block or blocks.
In some embodiments, the systems and/or computer program products of the invention are for use in performing the methods of the invention.
In some embodiments, change in the difference in intensities between an intensity of an odd order and intensity of an even order correlate to a change in effective optical depth. In some embodiments, the intensity of the even order is subtracted from the intensity of the odd order. In some embodiments, the intensity of the odd order is subtracted from the intensity of the even order. In some embodiments, an increase in effective optical depth indicates an increase in the amount of cellular material in said at least one compartment. In some embodiments, the system is optimized and/or calibrated in order to correlate the deviations in diffraction orders to the relative growth of said microorganism. In some embodiments, determining changes in effective optical depth comprises calibration of the diffraction orders' intensity with media of known refraction index. Diffraction indices for commonly used media are well known in the art or can be arrived at empirically by performing the detection of the invention with wells with no cells. In some embodiments, at least one grating is a control grating. In some embodiments, the control grating does not include biomaterial or cellular material. In some embodiments, the control grating is used to calibrate the detector and/or the signal processing unit. In some embodiments, a control standard is predetermined before performing the methods of the invention. In some embodiments, a result from a control grating is already provided such that they can be used for calibration without performing the control in parallel with the test well. In some embodiments, determining changes in effective optical depth comprises calibration of the detector by detecting diffraction orders' intensity obtained from illuminating a diffraction grating absent the at least one cell or sample. In some embodiments, a control diffraction grating is a grating that has not be inoculated with a cell. In some embodiments, a control diffraction grating is a grating that has only cell growth media. In some embodiments, the system comprises results from a control grating. In some embodiments, the signal processing unit comprises results from a control grating or a control experiment. In some embodiments, the system and/or the signal processing unit is preloaded with results from a control or a control experiment.
In some embodiments, the inoculating is with at least one cell. In some embodiments, the inoculating is with at least 1, 10, 100, 200, 300, 400, or 500 cells. Each possibility represents a separate embodiment of the invention. In some embodiments, the inoculating is with at least 400 cells. In some embodiments, the inoculation is with a solution comprising at least 10{circumflex over ( )}1, 10{circumflex over ( )}2, 10{circumflex over ( )}3, 10{circumflex over ( )}4, 10{circumflex over ( )}5, 10{circumflex over ( )}6, 10{circumflex over ( )}7 or 10{circumflex over ( )}8 cells/ml. Each possibility represents a separate embodiment of the invention. In some embodiments, the inoculating is with a solution comprising at least 10{circumflex over ( )}3 cells/ml. In some embodiments, the solution comprises about 10{circumflex over ( )}3 cells per ml. In some embodiments, the solution comprises about 10{circumflex over ( )}3 cells per ml and about 0.4 ml is inoculated.
In some embodiments, the inoculating results in at least 3 cells per square millimeter of diffraction grating. In some embodiments, the inoculating results in at least 1, 2, 3, 4, 5, 10, 15, 20, 25, or 30 cells per square millimeter of diffraction grating. Each possibility represents a separate embodiment of the invention.
In some embodiments, the methods of the invention can be performed in less than 10 minutes, 30 minutes, 45 minutes, 1 hour, 1.5 hours, 2 hours, 2.5 hours 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 10 hours, 15 hours, 20 hours, or 24 hours. Each possibility represents a separate embodiment of the invention. In some embodiments, the methods of the invention can be performed in about 30 minutes. In some embodiments, the methods of the invention can be performed in about 90 minutes. In some embodiments, the methods of the invention can be performed in less than 3 hours. In some embodiments, the methods of the invention can be performed in less than 4 hours. In some embodiments, the methods of the invention can be performed in less than 6 hours. In some embodiments, determining a change in amount of cellular material occurs in less than 10 minutes, 30 minutes, 45 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 10 hours, 15 hours, 20 hours, or 24 hours. Each possibility represents a separate embodiment of the invention. In some embodiments, determining a change in amount of cellular material occurs in less than 3 hours. In some embodiments, determining a change in amount of cellular material occurs in about 30 minutes. In some embodiments, determining a cell replication rate occurs in less than 10 minutes, 30 minutes, 45 minutes, 1 hour, 1.5 hours, 2 hours, 2.5 hours 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 10 hours, 15 hours, 20 hours, or 24 hours. Each possibility represents a separate embodiment of the invention. In some embodiments, determining a cell replication rate occurs in less than 90 minutes. In some embodiments, determining a cell replication rate occurs in less than 3 hours. In some embodiments, determining a cell replication rate occurs in about 30 minutes. It will be understood that the amount of time the methods of the invention require will be dependent on the rate of replication and/or growth of the biological material in the grating as well as the initial starting about of material or cells, thus faster replicating/growing biologicals as well as greater starting number and/or amount will be able to be analyzed faster.
In some embodiments, the methods of the invention can be performed, determining a change in amount of cellular material occurs, or determining a cell replication rate, within between 30 minutes and 3 hours, 30 minutes and 4 hours, 30 minutes and 6 hours, 30 minutes and 8 hours, 30 minutes and 10 hours, 30 minutes and 12 hours, 20 minutes and 24 hours, 1 hour and 3 hours, 1 hour and 4 hours, 1 hour and 6 hours, 1 hour and 8 hours, 1 hour and 10 hours, 1 hour and 12 hours, or 1 hour and 24 hours. Each possibility represents a separate embodiment of the invention. In some embodiments, the methods of the invention can be performed, determining a change in amount of cellular material occurs, or determining a cell replication rate occurs within between 30 minutes and 3 hours. In some embodiments, the methods of the invention can be performed, determining a change in amount of cellular material occurs, or determining a cell replication rate, in at least 90 minutes. In some embodiments, the methods of the invention can be performed, determining a change in amount of cellular material occurs, or determining a cell replication rate, in not more than 90 minutes.
In some embodiments, the inoculation is with at least 1, 3, 5, 10, 15, 20, 30, 40, 50, 100, 200, 300, 400, or 500 cells. Each possibility represents a separate embodiment of the invention. In some embodiments, the inoculation is with at least 10 cells. In some embodiments, the inoculation is with at least 3 cells. In some embodiments, the inoculation is with at least 3 cells per square millimeter of diffraction grating. In some embodiments, the inoculation is with at least 1, 3, 5, 10, 15, 20, 30, 40, 50, 100, 200, 300, 400 or 500 cells/ml in an inoculation solution. Each possibility represents a separate embodiment of the invention. In some embodiments, the inoculation is with at least 10 cells/ml in an inoculation solution. In some embodiments, the inoculation is with about 300 cells.
In some embodiments, the inoculation is with at least 3 cells per square millimeter of diffraction grating and the method of the invention is performed in not more than 90 minutes. In some embodiments, the diffraction grating comprises a cell attractant. In some embodiments, the cell attractant facilitates performance of the method within 90 minutes with as few as 3 cells per square millimeter of diffraction grating.
In some embodiments, the methods of the invention are performed with at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% accuracy. Each possibility represents a separate embodiment of the invention. In some embodiments, the methods of the invention are performed with at least 95% accuracy. In some embodiments, detection of cellular replication is performed with 95% accuracy. In some embodiments, detection of the presence of a cell in a sample is performed with 95% accuracy. As used herein, the term “accuracy” refers to the correct identification of changes in optical depth in the diffraction grating. Thus, an accuracy of 95% would mean that if 100 grating were measured for biomaterial growth and/or replication the system would correctly identify that growth or replication at least 95 times. In some embodiments, the accuracy is in positive detection of growth and/or replication. In some embodiments, the accuracy is in not detecting growth and/or replication in a diffraction grating in which it did not occur. In some embodiments, accuracy comprises the false positive rate. In some embodiments, accuracy comprises the false negative rate. In some embodiments, the false negative rate is less than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1 or 0%. Each possibility represents a separate embodiment of the invention. In some embodiments, the false negative rate is less than 5%. In some embodiments, the false negative rate is less than 1%. In some embodiments, the false positive rate is less than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1 or 0%. Each possibility represents a separate embodiment of the invention. In some embodiments, the false positive rate is less than 5%. In some embodiments, the false positive rate is less than 4%. In some embodiments, the system of the invention comprises the above recited accuracy, false positive rate and/or false negative rate.
In some embodiments, the infection is a bacterial infection. In some embodiments, the infection is a fungal infection. In some embodiments the infection is a yeast infection. In some embodiments, the infection is a bacterial, fungal or yeast infection. In some embodiments, the microorganism originated from an infection selected from a urinary infection, a vaginal infection, a respiratory infection, a cerebral infection, a bowel infection, a blood infection, a liver infection, a cardiac infection, and a cerebrospinal fluid infection.
In some embodiments, the subject is naïve to treatment for the infection. In some embodiments, the subject has undergone treatment for the infection. In some embodiments, the treatment was ineffective. In some embodiments, the treatment was effective. In some embodiments, the subject has not yet received treatment, has undergone ineffective treatment, or has undergone effective treatment. In some embodiments, the subject is suspected of having an infection. In some embodiments, the methods of the invention are used for determining an infection. In some embodiments, the methods of the invention are used for monitoring infection progression. In some embodiments, the methods of the invention are used for monitoring infection remission. In some embodiments, the methods of the invention are used for monitoring continuation of an infection-free state in the subject. In some embodiments, the methods of the invention are used for selecting a therapeutic agent for the infection.
In some embodiments, the methods of the invention further comprise adding a test agent to the grating after inoculation, wherein the test agent has the potential to alter the optical properties of the at least one cell. In some embodiments, altering the optical properties of a cell comprises at least one of altering replication, altering the cell cycle, altering cell secretion, altering cellular metabolism, altering cell viability, and altering cell survival. In some embodiments, an optical property of a cell is indicative of at least one of cell viability, cell replication, cell motility, cellular metabolism, protein production, lipid production, volume expansion and secretion. In some embodiments, an optical property of a cell is at least one of cell volume, cell mass and cell density.
In some embodiments, the at least one therapeutic agent and or test agent is selected from an antibiotic, a chemotherapeutic, a radioisotope, a fungicide, an antiviral agent, a biostatic agent, an antibody, an immune cell and a virus. In some embodiments, the at least one therapeutic agent or test agent is an antibiotic. In some embodiments, different therapeutic agents are applied to different gratings. In some embodiments, different concentrations of a therapeutic agent are applied to different gratings. In some embodiments, the methods of the invention are used to determine a minimum inhibitory concentration (MIC) of a therapeutic agent.
As used herein, the term “about” when combined with a value refers to plus and minus 10% of the reference value. For example, a length of about 1000 nanometers (nm) refers to a length of 1000 nm+−100 nm.
It is noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a polynucleotide” includes a plurality of such polynucleotides and reference to “the polypeptide” includes reference to one or more polypeptides and equivalents thereof known to those skilled in the art, and so forth. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation.
In those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.”
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable sub-combination. All combinations of the embodiments pertaining to the invention are specifically embraced by the present invention and are disclosed herein just as if each and every combination was individually and explicitly disclosed. In addition, all sub-combinations of the various embodiments and elements thereof are also specifically embraced by the present invention and are disclosed herein just as if each and every such sub-combination was individually and explicitly disclosed herein.
Additional objects, advantages, and novel features of the present invention will become apparent to one ordinarily skilled in the art upon examination of the following examples, which are not intended to be limiting. Additionally, each of the various embodiments and aspects of the present invention as delineated hereinabove and as claimed in the claims section below finds experimental support in the following examples.
Various embodiments and aspects of the present invention as delineated hereinabove and as claimed in the claims section below find experimental support in the following examples.
Generally, the nomenclature used herein, and the laboratory procedures utilized in the present invention include molecular, biochemical, microbiological and recombinant DNA techniques. Such techniques are thoroughly explained in the literature. See, for example, “Molecular Cloning: A laboratory Manual” Sambrook et al., (1989); “Current Protocols in Molecular Biology” Volumes I-III Ausubel, R. M., ed. (1994); Ausubel et al., “Current Protocols in Molecular Biology”, John Wiley and Sons, Baltimore, Md. (1989); Perbal, “A Practical Guide to Molecular Cloning”, John Wiley & Sons, New York (1988); Watson et al., “Recombinant DNA”, Scientific American Books, New York; Birren et al. (eds) “Genome Analysis: A Laboratory Manual Series”, Vols. 1-4, Cold Spring Harbor Laboratory Press, New York (1998); methodologies as set forth in U.S. Pat. Nos. 4,666,828; 4,683,202; 4,801,531; 5,192,659 and 5,272,057; “Cell Biology: A Laboratory Handbook”, Volumes I-III Cellis, J. E., ed. (1994); “Culture of Animal Cells—A Manual of Basic Technique” by Freshney, Wiley-Liss, N. Y. (1994), Third Edition; “Current Protocols in Immunology” Volumes I-III Coligan J. E., ed. (1994); Stites et al. (eds), “Basic and Clinical Immunology” (8th Edition), Appleton & Lange, Norwalk, Conn. (1994); Mishell and Shiigi (eds), “Strategies for Protein Purification and Characterization—A Laboratory Course Manual” CSHL Press (1996); all of which are incorporated by reference. Other general references are provided throughout this document.
The grating grids were fabricated from Silicon wafers and underwent thermal oxidation to produce a stable external layer of silicon with a thickness of about 100 nm. The gratings were cleaned with H2SO4/H2O2 solution and their surface were further modified to include isopropenyl-esters or propylmethcrylate as surface functional groups. Before use, the gratings were wetted with ethanol and placed within the device detection channels.
In a standard set-up illustrated in
Light passing through an optical grating produces a diffraction pattern.
The light intensity at diffraction angle θ for each order m, is distributed as:
For each diffraction order m, intensity values reach their maxima depending on the grating optical depth w (n1−n2):
Due to the term sinc2 (m/2), odd orders intensities shift in opposite direction to even orders intensities. Thus, I(odd)−I(even) will change when w (n1−n2) does. This relationship can be termed in short as ΔIm∝Δn. An example of a hypothetical refraction analysis is presented in
Eq.1 should be viewed as sine series modulated by the cosine terms. The sinus phase number is denoted by g, that is the number of maxima or minima, gmax or gmin, that precedes it.
For gmax, min=0; the transformation is y=Arccos(1−2x)/2
For gmax=1, 2, 3 . . . ; the transformation is y=Arcsin(1−2x)/2+p*g
For gmin=1, 2, 3 . . . ; the transformation is y=Arccos(1−2x)/2+p*g
Where p is a correction factor related to the specifics of the gratings manufacturing variations and is determined experimentally. For the grating of the example given in
The limit of detection (LOD) refers to the minimal concentration of bacteria in a sampled suspension, that can be positively detected within the device of the invention.
To improve the LOD and reduce the lag phase, an improved surface treatment that allows the semi-stable adsorption of sucrose molecules to the gratings was developed. The semi-stable sucrose deposit can sustain a concentration gradient in the solution above the grating that attracts bacteria cells through active chemotaxis. This was achieved by increasing the number of potential hydrogen bonds between the sugar side groups and the surface, through the addition of double bond oxygen molecules to the surface. The surface was then loaded by contact with a 2% sucrose solution in pH 8.
In applying the chemotaxis approach, lower bacteria starting concentration can be used to colonize the grating, both improving the LOD and truncating the lag phase.
In order to determine the practical limit of detection as a number of cells per square millimeter of grating, 0.3 ml of diluted bacteria suspension was flowed onto a diffraction grating. Three concentrations of cells were tested, 30 cells per mm2, 3 cells per mm2 and less than 3 cells per mm2 (
E. coli cells were inoculated into a well of the diffraction grating containing bacterial growth media and allowed to replicate freely. First and second order diffraction from this well, and a well containing only media, were monitored for 3 hours (
As the bacterial colonies are analyzed at sub-cell precision, changes can be observed even prior to the completion of a replication cycle. This aids completion of the analysis after very short incubation times. As explained above, the physical presence of a bacterium inside the grating contribute to the time-dependent change in grating optical depth and hence is expected to promote the difference between the intensity of odd diffraction orders and even ones. As the cells replicate, the growth in biomass, proportionally increase the optical depth, further widening the intensity gap between the diffraction orders.
In order to confirm that the system accurately predicts bacterial growth, samples of three bacterial strains (K. pneumonia, P. Mirabilis and E. Coli) were isolated from clinical urine samples from patients at the Laniado Medical Center in Netanya Israel. Bacteria colonies were inoculated in Muller-Hinton broth and the cell concentration in suspension was calculated by optical density analysis, followed by diluted to 104 cell/ml in phosphate buffered water.
Each optical micro-fluidic channel in the system was prepared with a diffraction grating chip possessing chemo-attractant properties. Each channel in the system was an independent unit and was illuminated continuously with a dedicated laser source. 0.3 ml of bacterial suspension sample were added into each micro-fluidic channel, and incubated there for 30 min. Next, each micro-fluidic channel was rinsed with 0.5 ml of Enterobacteriaceae selective growth medium (McConkey), with or without antibiotics (1 μg Gentamycin). For K. Pneumonia, 24 samples were collected, of which 9 were grown in the presence of Gentamycin. For P. Mirabilis, 33 samples were collected, of which 12 were grown in the presence of Gentamycin. For E. Coli, 26 samples were collected, 15 of which were grown in the presence of Gentamycin. Laser diffraction reflected from each of the channels produced a diffraction image, that was recorded every 1 min, for 120 min. Image data was automatically analyzed to extract the intensity of each diffraction spot at every image. Experiments that suffered from documented mechanicals faults were excluded from further analysis.
For every experiment the trend in the relative diffraction intensity over time was calculated. Experiments that included strong deviations of >50% from trend line during the final 30 min, were excluded from the results. Shift, defined as the relative difference between the diffraction intensity at the beginning and end of measuring was used to determine if growth occurred. As all strains were antibiotic responsive, any well to which Gentamycin was added were expected to not have growth. For each bacteria, all gratings with expected growth were indeed measured to have growth within the 120 minutes of analysis. One false positive was also measured for each bacteria (Table 1). Thus, for measuring K. Pneumonia growth the system of the invention was 95.8% accurate, for P. Mirabilis the system was 96.9% accurate, for E. Coli the system was 96.15% accurate, which amounts to a total accuracy of over 96%.
K.
Pneumonia
P. Mirabilis
E. Coli
E. coli cells were inoculated into wells of the grating grid functionalized with semi-stable sucrose, as described herein, at a concentration of 10{circumflex over ( )}4 cells/ml. Following the inoculation step, nutrient media was supplied while the diffractive optical output was monitored. The bacteria were grown for 60 min, before the device channels were supplemented with varying concentrations of G418 (Geneticin) antibiotic.
By monitoring the diffraction over time, a range for minimum inhibitory concentration (MIC) was established (
Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.
This application claims the benefit of priority of U.S. Provisional Patent Application No. 62/627,797, filed Feb. 8, 2018, the contents of which are all incorporated herein by reference in their entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/IL2019/050154 | 2/7/2019 | WO | 00 |
